Sun, L.; Zheng, Z.-M.; Shao, C.-S.; Zhang, Z.-Y.; Li, M.-W.; Wang, L.; Wang, H.; Zhao, G.-H.; Wang, P.
Rational Design by Structural Biology of Industrializable, Long-Acting Antihyperglycemic GLP-1 Receptor Agonists. Pharmaceuticals 2022, 15, 740.
https://doi.org/10.3390/ph15060740
AMA Style
Sun L, Zheng Z-M, Shao C-S, Zhang Z-Y, Li M-W, Wang L, Wang H, Zhao G-H, Wang P.
Rational Design by Structural Biology of Industrializable, Long-Acting Antihyperglycemic GLP-1 Receptor Agonists. Pharmaceuticals. 2022; 15(6):740.
https://doi.org/10.3390/ph15060740
Chicago/Turabian Style
Sun, Lei, Zhi-Ming Zheng, Chang-Sheng Shao, Zhi-Yong Zhang, Ming-Wei Li, Li Wang, Han Wang, Gen-Hai Zhao, and Peng Wang.
2022. "Rational Design by Structural Biology of Industrializable, Long-Acting Antihyperglycemic GLP-1 Receptor Agonists" Pharmaceuticals 15, no. 6: 740.
https://doi.org/10.3390/ph15060740
APA Style
Sun, L., Zheng, Z.-M., Shao, C.-S., Zhang, Z.-Y., Li, M.-W., Wang, L., Wang, H., Zhao, G.-H., & Wang, P.
(2022). Rational Design by Structural Biology of Industrializable, Long-Acting Antihyperglycemic GLP-1 Receptor Agonists. Pharmaceuticals, 15(6), 740.
https://doi.org/10.3390/ph15060740
